SG301 SC Injection

DRUG2 trials

Sponsors

Hangzhou Sumgen Biotech Co., Ltd.

Conditions

Systemic Lupus Erythematosus (SLE)

Phase 1

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

CompletedNCT06144710

Hangzhou Sumgen Biotech Co., Ltd.Systemic Lupus Erythematosus (SLE)

Start: 2023-11-10End: 2026-01-07Updated: 2026-08-11

Phase 2

To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

RecruitingNCT07447986

Hangzhou Sumgen Biotech Co., Ltd.Systemic Lupus Erythematosus (SLE)

Start: 2026-03-26End: 2027-12-31Target: 120Updated: 2026-09-17